Class II
Terminated
CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Ph…
Why: Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.
- Company
- Takeda Pharmaceuticals North America, Inc.
Deerfield, IL, United States - Reported
- Jul 8, 2015
- Recall started
- May 21, 2015
- Ended
- Feb 20, 2018
- Where sold
- Nationwide
- Amount
- 3,619 bottles
- Full product description
- CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Pharmaceuticals America, Inc., Deerfield, IL 60015, NDC 64764-890-99.
- Lots / codes affected
- Lot # B21642; Exp. 03/17
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.